Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06738407 · ClinicalTrials.gov registry record · Phase 4
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
A Phase 4 study, sponsored by Westat.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 760
- Enrollment target
NCT06738407 is a Phase 4 study that is actively recruiting participants, run by Westat. The registered enrollment target is 760 participants.
The verdict
NCT06738407, a Phase 4 study, is actively recruiting participants, sponsored by Westat.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 760 participants
- Enrollment target
Study Summary
The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.
Interventions
- DRUG Doxycycline hyclate delayed released 200 mg
- DRUG Doxycycline hyclate delayed released 200 mg weekly
- OTHER Per standard of care with quarterly STI testing/treatment and sexual health counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 760 participants |
| Start Date | 2026-02-27 |
| Est. Completion | 2028-06-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06738407
The ClinicalTrials.gov registry entry for NCT06738407 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 760 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Westat, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Doxycycline hyclate delayed released 200 mg is the first listed.
NCT06738407 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06738407 about?
NCT06738407 is a clinical study titled "Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections". The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform p...
What is the current status of trial NCT06738407?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 760 participants. The study started on 2026-02-27. Estimated completion is 2028-06-15.
What interventions are being tested in trial NCT06738407?
The interventions under investigation include: Doxycycline hyclate delayed released 200 mg (DRUG), Doxycycline hyclate delayed released 200 mg weekly (DRUG), Per standard of care with quarterly STI testing/treatment and sexual health counseling (OTHER).
Who is sponsoring clinical trial NCT06738407?
This trial is sponsored by Westat, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.